Published in Vaccine Weekly, April 27th, 2005
Study 1: Researchers report the results of a study on the role of tumor-derived exosomes in cancer-associated T-cell signaling defects in a recent issue of the British Journal of Cancer.
"Dendritic and lymphoid exosomes regulate immune activation. Tumors release membranous material mimicking these exosomes, resulting in deletion of reactive lymphocytes. Tumor-derived exosomes have recently been explored as vaccines, without analysis of their immunologic consequences. This investigation examines the composition of tumor-derived exosomes and their effects on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-04-27)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.